FRM
CBAY

Fox Run Management’s Cymabay Therapeutics CBAY Stock Holding History

Fox Run Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-24,852
Closed -$323K – 959
2018
Q1 		$323K Buy
+24,852
New +$323K 0.08% 468